
Chee-chong Lee
Examiner (ID: 18802, Phone: (571)270-1916 , Office: P/3752 )
| Most Active Art Unit | 3752 |
| Art Unit(s) | 3752 |
| Total Applications | 919 |
| Issued Applications | 489 |
| Pending Applications | 140 |
| Abandoned Applications | 313 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20401247
[patent_doc_number] => 12491207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability
[patent_app_type] => utility
[patent_app_number] => 17/982213
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10574
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982213
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982213 | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability | Nov 6, 2022 | Issued |
Array
(
[id] => 18725794
[patent_doc_number] => 20230340012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/975790
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/975790 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | Oct 27, 2022 | Pending |
Array
(
[id] => 18351255
[patent_doc_number] => 20230139366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BRARTEMICIN ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 18/047708
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047708
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047708 | BRARTEMICIN ANALOGUES | Oct 18, 2022 | Abandoned |
Array
(
[id] => 18162015
[patent_doc_number] => 20230028607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 17/960966
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/960966 | COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA | Oct 5, 2022 | Abandoned |
Array
(
[id] => 19778511
[patent_doc_number] => 12227535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Triterpene saponins, methods of synthesis and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/947716
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 38768
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947716 | Triterpene saponins, methods of synthesis and uses thereof | Sep 18, 2022 | Issued |
Array
(
[id] => 18518506
[patent_doc_number] => 11708386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root
[patent_app_type] => utility
[patent_app_number] => 17/946531
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4005
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 378
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946531 | Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root | Sep 15, 2022 | Issued |
Array
(
[id] => 18254107
[patent_doc_number] => 20230081146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS
[patent_app_type] => utility
[patent_app_number] => 17/931491
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931491 | METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS | Sep 11, 2022 | Abandoned |
Array
(
[id] => 18299334
[patent_doc_number] => 20230109020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes
[patent_app_type] => utility
[patent_app_number] => 17/941835
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941835 | Nucleic acid and other compositions and methods for the modulation of cell membranes | Sep 8, 2022 | Issued |
Array
(
[id] => 20316147
[patent_doc_number] => 12454691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Modified short interfering nucleic acid (siNA) molecules and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/939896
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 60553
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17939896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/939896 | Modified short interfering nucleic acid (siNA) molecules and uses thereof | Sep 6, 2022 | Issued |
Array
(
[id] => 18177133
[patent_doc_number] => 20230037862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => SYNTHETIC AGONISTS OF TLR4 RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/813140
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813140 | SYNTHETIC AGONISTS OF TLR4 RECEPTOR | Jul 17, 2022 | Abandoned |
Array
(
[id] => 18108018
[patent_doc_number] => 20230000898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/852453
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/852453 | COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES | Jun 28, 2022 | Abandoned |
Array
(
[id] => 20158200
[patent_doc_number] => 12384812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Proton activated atomic medicine
[patent_app_type] => utility
[patent_app_number] => 17/850467
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14665
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850467 | Proton activated atomic medicine | Jun 26, 2022 | Issued |
Array
(
[id] => 19464548
[patent_doc_number] => 20240318217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => A Method for Preparation of Glycolipid Carboxylic Acids
[patent_app_type] => utility
[patent_app_number] => 18/574060
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18574060
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/574060 | A Method for Preparation of Glycolipid Carboxylic Acids | Jun 23, 2022 | Pending |
Array
(
[id] => 17851812
[patent_doc_number] => 20220281854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMBINATION THERAPY FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/751153
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751153 | COMBINATION THERAPY FOR TREATING CANCER | May 22, 2022 | Abandoned |
Array
(
[id] => 17790445
[patent_doc_number] => 20220249536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => ANTIBODY DRUG CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/730924
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730924 | Antibody drug conjugates | Apr 26, 2022 | Issued |
Array
(
[id] => 17807418
[patent_doc_number] => 20220259253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => CD73 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/722513
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -123
[patent_words_short_claim] => 1087
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722513 | CD73 INHIBITORS | Apr 17, 2022 | Abandoned |
Array
(
[id] => 19650016
[patent_doc_number] => 12171776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Methods for treatment and prophylaxis of HIV and AIDS
[patent_app_type] => utility
[patent_app_number] => 17/658547
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9805
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/658547 | Methods for treatment and prophylaxis of HIV and AIDS | Apr 7, 2022 | Issued |
Array
(
[id] => 18109631
[patent_doc_number] => 20230002511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => HIGH-VISCOSITY LITHIUM CARBOXYMETHYL CELLULOSE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/681971
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681971 | High-viscosity lithium carboxymethyl cellulose and preparation method therefor and application thereof | Feb 27, 2022 | Issued |
Array
(
[id] => 17670944
[patent_doc_number] => 20220184111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
[patent_app_type] => utility
[patent_app_number] => 17/682655
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682655 | METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY | Feb 27, 2022 | Abandoned |
Array
(
[id] => 17687687
[patent_doc_number] => 20220194979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR PREPARING DELPHINIUM ACYLATED ANTHOCYANIN
[patent_app_type] => utility
[patent_app_number] => 17/674860
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674860 | Method for preparing delphinium acylated anthocyanin | Feb 17, 2022 | Issued |